
Robert B. Mondesi
Examiner (ID: 1064)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1653, 1652, 1645 |
| Total Applications | 430 |
| Issued Applications | 174 |
| Pending Applications | 97 |
| Abandoned Applications | 165 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6176535
[patent_doc_number] => 20020155614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Peptide esterification'
[patent_app_type] => new
[patent_app_number] => 10/081379
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10306
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155614.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081379 | Peptide esterification | Feb 20, 2002 | Abandoned |
Array
(
[id] => 456662
[patent_doc_number] => 07244721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 10/052386
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50340
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244721.pdf
[firstpage_image] =>[orig_patent_app_number] => 10052386
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/052386 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Jan 17, 2002 | Issued |
Array
(
[id] => 6711112
[patent_doc_number] => 20030170861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Cellobiohydrolase I gene and improved variants'
[patent_app_type] => new
[patent_app_number] => 10/031496
[patent_app_country] => US
[patent_app_date] => 2002-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7934
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031496 | Cellobiohydrolase I gene and improved variants | Jan 13, 2002 | Issued |
Array
(
[id] => 968423
[patent_doc_number] => 06939697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Process to concentrate insoluble proteins by vibrating membrane filtration'
[patent_app_type] => utility
[patent_app_number] => 10/250818
[patent_app_country] => US
[patent_app_date] => 2002-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10317
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939697.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250818 | Process to concentrate insoluble proteins by vibrating membrane filtration | Jan 6, 2002 | Issued |
Array
(
[id] => 1030962
[patent_doc_number] => 06878513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-12
[patent_title] => 'Modified gelatin, and silver halide photographic emulsion and photographic light-sensitive material using the same'
[patent_app_type] => utility
[patent_app_number] => 10/026843
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50788
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026843 | Modified gelatin, and silver halide photographic emulsion and photographic light-sensitive material using the same | Dec 26, 2001 | Issued |
Array
(
[id] => 999577
[patent_doc_number] => 06911428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-28
[patent_title] => 'Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 10/013071
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16033
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/911/06911428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013071 | Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus | Dec 9, 2001 | Issued |
Array
(
[id] => 6710879
[patent_doc_number] => 20030170628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Human cDNAs and proteins and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/999570
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 191874
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170628.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999570
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999570 | Human cDNAs and proteins and uses thereof | Nov 13, 2001 | Issued |
Array
(
[id] => 642196
[patent_doc_number] => 07122629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Human cDNAs and proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/001142
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 190635
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001142
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001142 | Human cDNAs and proteins and uses thereof | Nov 13, 2001 | Issued |
Array
(
[id] => 6847344
[patent_doc_number] => 20030166511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Cardioprotective composition comprising ceruloplasmin and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/021691
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9255
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166511.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021691
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021691 | Cardioprotective composition comprising ceruloplasmin and uses thereof | Nov 4, 2001 | Abandoned |
Array
(
[id] => 707379
[patent_doc_number] => 07060462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'AopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display'
[patent_app_type] => utility
[patent_app_number] => 10/415554
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28313
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060462.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415554
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415554 | AopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display | Oct 31, 2001 | Issued |
Array
(
[id] => 7399482
[patent_doc_number] => 20040039177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Stimulus responsive affinity chromatographic material and separation/purification method'
[patent_app_type] => new
[patent_app_number] => 10/381120
[patent_app_country] => US
[patent_app_date] => 2003-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7357
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20040039177.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381120 | Stimulus responsive affinity chromatographic material and separation/purification method | Oct 14, 2001 | Issued |
Array
(
[id] => 560795
[patent_doc_number] => 07157565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Far red shifted fluorescent proteins'
[patent_app_type] => utility
[patent_app_number] => 09/976673
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16529
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157565.pdf
[firstpage_image] =>[orig_patent_app_number] => 09976673
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/976673 | Far red shifted fluorescent proteins | Oct 11, 2001 | Issued |
Array
(
[id] => 843811
[patent_doc_number] => 07388075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-17
[patent_title] => 'Medicament containing activated antithrombin III'
[patent_app_type] => utility
[patent_app_number] => 10/380274
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 31
[patent_no_of_words] => 13041
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/388/07388075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380274
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380274 | Medicament containing activated antithrombin III | Sep 11, 2001 | Issued |
Array
(
[id] => 6834700
[patent_doc_number] => 20030162246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Methods of synthesizing cell-free protein'
[patent_app_type] => new
[patent_app_number] => 10/344803
[patent_app_country] => US
[patent_app_date] => 2003-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8048
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162246.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344803
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344803 | Methods of synthesizing cell-free protein | Aug 27, 2001 | Issued |
Array
(
[id] => 6016049
[patent_doc_number] => 20020102709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Collagen-binding physiologically active polypeptide'
[patent_app_type] => new
[patent_app_number] => 09/934706
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22872
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102709.pdf
[firstpage_image] =>[orig_patent_app_number] => 09934706
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/934706 | Collagen-binding physiologically active polypeptide | Aug 22, 2001 | Abandoned |
Array
(
[id] => 7394271
[patent_doc_number] => 20040038370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Claudin polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/344487
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31576
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344487 | Claudin polypeptides | Aug 14, 2001 | Issued |
Array
(
[id] => 7329809
[patent_doc_number] => 20040254117
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2004-12-16
[patent_title] => 'Novel peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => corrected
[patent_app_number] => 09/908955
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39724
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0254/20040254117.pdf
[firstpage_image] =>[orig_patent_app_number] => 09908955
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/908955 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Jul 18, 2001 | Issued |
Array
(
[id] => 543002
[patent_doc_number] => 07169760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 09/909012
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21124
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169760.pdf
[firstpage_image] =>[orig_patent_app_number] => 09909012
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/909012 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Jul 18, 2001 | Issued |
Array
(
[id] => 7329809
[patent_doc_number] => 20040254117
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2004-12-16
[patent_title] => 'Novel peptides as NS3-serine protease inhibitors of hepatitis C virus'
[patent_app_type] => corrected
[patent_app_number] => 09/908955
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39724
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0254/20040254117.pdf
[firstpage_image] =>[orig_patent_app_number] => 09908955
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/908955 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | Jul 18, 2001 | Issued |
Array
(
[id] => 843605
[patent_doc_number] => 07387993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-17
[patent_title] => 'Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-αinhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/332712
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7018
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/387/07387993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332712
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332712 | Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-αinhibitors | Jul 12, 2001 | Issued |